Medici wins Endpoints 2026 award, touts personalized cancer therapy
read at Endpoints ↗Positive
Medici was announced as the winner of the Endpoints 2026 competition.
The company said its approach focuses on tailoring cancer treatments to individual patients.
The award highlights growing interest in personalized oncology, though details of the technology were not provided.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Endpoints 11 2026 winner Medici believes the future of cancer therapy is personalized”
read at Endpoints ↗85 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that